MedTrace Logo

Alpers Huttenlocher Natural History Study

NCT03034512 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 2

Last updated 2022-08-01

No results posted yet for this study

Summary

This is a natural history study of Alpers Huttenlocher Syndrome. Patients will be followed over time to assess clinical symptoms for the purpose of expanding knowledge of this disorder in the medical community.

Conditions

  • Alpers Huttenlocher Syndrome

Sponsors & Collaborators

  • Seattle Children's Hospital

    collaborator OTHER

  • National Institute of Neurological Disorders and Stroke (NINDS)

    collaborator NIH

  • Columbia University

    lead OTHER

Principal Investigators

  • Michio Hirano, MD · Columbia University

  • Russell Saneto, MD · Seattle Children's Hospital

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2022-07-27
Completion
2022-07-27

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03034512 on ClinicalTrials.gov